Galenea -

Careers

Contact

News | Publications

News

10/06/2008	Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration









05/21/2007	Galenea Corp. Appoints Mark Benjamin as Chief Executive Officer









04/07/2006	Galenea To Focus On Development Of CNS Drugs









02/23/2006	Nastech Pharmaceutical Company Inc. (NSTK) Acquires RNAi Therapeutics Program Targeting Influenza From Galenea









11/17/2005	Galenea Corp. Awarded Phase I SBIR To Develop siRNA Products for Prevention and Treatment of Influenza Infection









02/16/2005	Galenea Corp. Signs Collaboration and License Agreement with Otsuka Pharmaceutical Co., Ltd.

Next Publications »

300 Technology Square
2nd Floor
Cambridge, MA 02139

(617) 374-1010
Fax (617) 374-1320
Info@Galenea.com